Analyst Explains Why He’s Investing in This Top Biotech ETF
“But this is a subsector that’s been under the mat for quite some time. So it’s nice to see some price action there. So couple things for me.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Two Sigma Advisors John Overdeck And David Siegel | 557,807 | $94,185,712 | 0.08% | |
| 2. | D E Shaw D. E. Shaw | 389,056 | $65,692,106 | +892% | 0.04% |
| 3. | Leucadia National Ian Cumming And Joseph Steinberg | 302,307 | $51,044,505 | +1% | 0.35% |
| 4. | 156,400 | $26,408,140 | -2% | 0% | |
| 5. | 91,500 | $15,449,775 | -66% | 0% |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 116,115 | $22,083,912 | 1.05% | |
| 2. | 61,030 | $11,607,345 | 0.95% | |
| 3. | 57,530 | $11,404,083 | 0.16% | |
| 4. | 52,885 | $10,058,198 | 5.63% | |
| 5. | 49,988 | $9,507,218 | 0.17% |